/
ELV
$376.40+$0.42 (+0.11%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$81.6B
217M shares
52-week range
$273.71 – $436.24
63% from low
Sector
HOSPITAL & MEDICAL SERVICE PLANS
Exchange
NYSE
CS
Change$-96.69
Elevance Health, Inc.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
www.elevancehealth.com- Employees
- 97,100
- IPO / List date
- Oct 30, 2001
- HQ
- INDIANAPOLIS, IN
Held by traders on TradeandTell
No one on the platform currently holds ELV.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2025-09-30 | 55,203 | $17.8M |
| Renaissance Technologiesas of 2026-03-31 | 15,573 | $4.6M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 1.83% ($6.87/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-09-10 | $1.7200 | 2026-09-25 |
| 2026-06-10 | $1.7200 | 2026-06-25 |
| 2026-03-10 | $1.7200 | 2026-03-25 |
| 2025-12-05 | $1.7100 | 2025-12-19 |
| 2025-09-10 | $1.7100 | 2025-09-25 |
| 2025-06-10 | $1.7100 | 2025-06-25 |
| 2025-03-10 | $1.7100 | 2025-03-25 |
| 2024-12-05 | $1.6300 | 2024-12-20 |
| 2024-09-10 | $1.6300 | 2024-09-25 |
| 2024-06-10 | $1.6300 | 2024-06-25 |
Recent trades on TradeandTell
No one on the platform has traded ELV yet.
